Laidlaw Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

October 8, 2024 2:57 PM EDT Send to a Friend
Laidlaw analyst Yale Jen reiterated a Buy rating and $75.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login